MA
₹27.49
-1.07(-3.75%)
MANGALAM₹27.49-3.75%
36/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %MANGALAM financial summary
For Mar 2026, Mangalam Drugs And Organics Limited reported revenue of ₹232 crore, which fell 27.0% from the previous year. Net profit was -₹44 crore, which fell 728.6% year on year, on an operating margin of -6%. Earnings per share came in at -₹27.68. Over the 5 years from Mar 2021 to Mar 2026, revenue changed at a compound annual rate of -9.4%. The highest operating margin in that period was 14% in Mar 2021. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹232 crore |
|---|---|
| Net profit | -₹44 crore |
| Operating margin | -6% |
| EPS | -₹27.68 |